Olaplex Holdings, Inc. (OLPX)

SEC filings show the stock is effectively a deal-closure bet: the 10-Q filed 2026-05-11 discloses a Henkel merger where each share converts to $2.06 in cash, which anchors the current price and limits upside. Stand-alone performance has deteriorated (2021–2025 revenue CAGR -8.31%, EBITDA CAGR -30.52%) and trailing profitability is negative (TTM net margin -3.53%, ROIC -0.43%). Liquidity/leverage are supportive (cash ~$326M at 2026-03-31 per 10-Q, net debt/EBITDA 0.36, Altman Z 2.57), but operating earnings do not cover interest (TTM interest coverage -0.19) and beta is high (1.86).

Short-term narrative is dominated by the pending Henkel $2.06/share cash acquisition (ongoing_process; widely reported), which appears largely priced in and leaves media sentiment neutral vs a slightly negative 30–90d baseline. Confirmed ongoing litigation (court-record backed) remains a moderate overhang, keeping the setup more “wait-for-close” than a fresh catalyst and effectively capping conviction at 3.

Trend signals are constructive because price is above the 20/50/200-day averages and the 9/21-day EMAs, while RSI is near 60 and MACD is modestly positive above zero. However, ATR and StdDev are very small, Williams %R is mid-range, and the past month has been a tight 2.03-2.06 box rather than a fresh breakout, so the chart grades mixed instead of high-conviction.